Skip to main content

JOINT Corp

corporate_fare Company Profile

JOINT Corp

JYNT·NASDAQ·Real Estate & Construction·CIK 0001612630

The Joint Corp. is a franchisor and operator of chiropractic clinics, focused on providing routine and affordable chiropractic care through a private pay, non-insurance, cash-based model. The company aims to be a leading provider and the most recognized brand in the chiropractic industry. In 2025, the company delivered over 14.4 million patient visits, generating over $532.4 million in system-wide sales. This is a decrease from 14.7 million patient visits and $530.3 million in system-wide sales in 2024. The Joint Corp. operates a highly franchised network of modern, consumer-friendly clinics that employ licensed chiropractors. This model allows the company to price its services below most competitors and typical insurance co-payment levels. Since acquiring its predecessor in March 2010, the company has expanded from eight to 960 clinics in operation as of December 31, 2025. As of the same date, franchisees owned or managed 885 clinics, and the company owned or managed 75 clinics. Additionally, 82 franchise licenses were sold but not yet developed, and there were 57 letters of intent for 57 future clinic licenses. The company collects a royalty of 7.0% of gross sales from franchised clinics, remitting a 3.0% royalty to regional developers for franchises within their protected territories. A national marketing fee of 2.0% of gross sales is also collected from all franchised clinics. The company's expansion is focused on key markets throughout North America.

JOINT Corp (NASDAQ:JYNT) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 11 items for JYNT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-06, rated 7/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for JYNT spans 10-Q, 4, 8-K, DEF 14A.

Recent high-impact activity:

  • JOINT Corp Beats Q2 Revenue, Swings to H1 Profit as Refranchising Gains Traction
  • Joint Corp Q2 Revenue Beats, Reiterates 2026 Outlook
  • 10% Owner Charles Jobson Buys $1.27M in JOINT Corp Stock
  • JOINT Corp Secures Default Waiver, Extends Credit, Reports Mixed Q1 Results Amid Refranchising
  • JOINT Corp Advances Pure-Play Franchisor Strategy with Partial Closing of 45-Clinic Sale

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$54.9M
Net Income
$2.91M
Diluted EPS
$0.19
Op. Cash Flow
$1.84M
Free Cash Flow
$334.72K
Gross Profit
$43.67M
Operating Income
-$913.38K
Cash & Equivalents
$23.6M
Debt / Equity
0.00×
Net Margin
5.3%
Shares Outstanding
14.14M sh
Source: 10-K · filed 2026-03-12 · accession 0001612630-26-000022

Short Interest & Short Volume

4.89 days to cover

FINRA reported short interest of 439,478 shares in JYNT as of the September 15, 2026 settlement, a 10.0% increase from the prior period — about 4.9 days to cover at its recent average daily volume. On September 25, 2026, 18.4% of JYNT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)439,478 shares as of September 15, 2026
Change vs prior period▲ 10.0%
Days to cover4.89 at avg daily volume of 89,812
Daily short volume (FINRA facilities)18.4% of 28,083 shares on September 25, 2026
5-day average short volume27.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with J →
$8.23
52-week range · as of 2026-08-06 $7.5 – $11.26
Market cap
$116.4M
Volume
62.1K (0.7× avg)
3-mo avg 83.1K
Live data · 2026-09-28 05:10 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed JYNT - Latest Insights

JYNT
Aug 06, 2026, 6:40 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.15
Real-time Price: $8.23 info
Change: +$0.080 (+0.98%) info
Market Cap: $116.398M info
JYNT
Aug 06, 2026, 4:52 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $8.22
Real-time Price: $8.23 info
Change: +$0.0100 (+0.12%) info
Market Cap: $116.398M info
JYNT
May 14, 2026, 6:00 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $8.32
Real-time Price: $8.23 info
Change: -$0.090 (-1%) info
Market Cap: $116.398M info
JYNT
May 07, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.67
Real-time Price: $8.23 info
Change: -$0.440 (-5%) info
Market Cap: $116.398M info
JYNT
May 01, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.90
Real-time Price: $8.23 info
Change: -$0.670 (-8%) info
Market Cap: $116.398M info
JYNT
Apr 24, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.02
Real-time Price: $8.23 info
Change: -$0.790 (-9%) info
Market Cap: $116.398M info
JYNT
Apr 07, 2026, 4:07 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $8.91
Real-time Price: $8.23 info
Change: -$0.680 (-8%) info
Market Cap: $116.398M info
JYNT
Mar 16, 2026, 7:07 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $8.23 info
Change: -$0.270 (-3%) info
Market Cap: $116.398M info
JYNT
Mar 12, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $8.21
Real-time Price: $8.23 info
Change: +$0.020 (+0.24%) info
Market Cap: $116.398M info
JYNT
Jan 09, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.24
Real-time Price: $8.23 info
Change: -$1.01 (-11%) info
Market Cap: $116.398M info
JYNT
Jan 07, 2026, 6:17 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $8.83
Real-time Price: $8.23 info
Change: -$0.600 (-7%) info
Market Cap: $116.398M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets